| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |